Positive: Regeneron's EYLEA HD shows sustained vision gains in wet AMD patients at 3 years.
From NASDAQ.: 2025-02-08 23:17:46 Regeneron Pharmaceuticals announced positive three-year results for EYLEA HD in patients with wet age-related macular degeneration.